Article | November 7, 2022

Lipid Nanoparticles: Tackling Solubility Challenges With Lipid-Based Technologies For Oral & Injectable Formulations

By Jim Huang, PhD, Founder & CEO, and Shauket Ali, PhD, Sr. Director, Scientific Affairs & Technical Marketing, Ascendia Pharmaceuticals

GettyImages-1346675538-lab-research-development-test tubes

Tremendous progress has been made throughout the years in drug formulations with the launch of new excipients and formulation technologies. However, with an increasing number of new chemical entities (NCEs), challenges remain, and drug manufacturers are open for adapting new technologies to expedite the clinical development and commercialization of these molecules.

With increased regulatory compliances, drug manufactures and contract manufacturers are also taking innovative approaches in designing and developing formulations to reduce pill burden and improve safety and efficacy of drug molecules.

In this article, learn more about the decision for selecting the right and most suited technology for formulating a complex molecule.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online